Introduction
============

Renal failure is an important complication of sepsis and CRRT with adsorbing membranes may be useful in this clinical setting \[[@B1]\]. The aims of the study in septic/septic shock patients are to evaluate: the safety of a new hemofilter membrane oXiris with adsorbing properties and anti-endotoxin activity; the renal and hemodynamic response; and the changes of endotoxin and proinflammatory molecules.

Methods
=======

Forty septic/septic shock patients with renal failure were enrolled in the study. All patients had preoperative endotoxin \>0.6 level/units (EAA Spectral D) and were submitted to high-volume hemodiafiltration (50 ml/kg/hour, Prismaflex; Gambro) with a new treated heparin-coated membrane (oXiris; Gambro). At T0 (pre-treatment) and T1 (24 hours) the main clinical and biochemical data were evaluated. All data are expressed as mean ± SD. One-way ANOVA test with Bonferroni correction was used to evaluate the data changes. *P*\< 0.05 was considered significant.

Results
=======

Table [1](#T1){ref-type="table"} presents the main results of this study.

  Parameter        Units          T0           T1
  ---------------- -------------- ------------ --------------
  Creatinine       mg/dl          1.9 ± 0.1    1.18 ± 0.1\*
  Diuresis         ml/24 hours    1,284 ± 78   1,573 ± 98
  Norepinephrine   μg/kg/minute   0.17 ± 0.2   0.06 ± 0.1\*
  IL-6             pg/ml          572 ± 78     278 ± 57\*
  Procalcitonin    ng/ml          35 ± 7       15 ± 2\*
  Endotoxin        Level/U        0.64 ± 0.2   0.49 ± 0.1

\**P \<*0.05 vs. T0.

Conclusion
==========

In septic/septic shock patients with renal failure, CRRT with a new treated heparin-coated membrane (oXiris; Gambro) is clinically feasible, and has a positive effect on renal function and hemodynamics. An adsorbing effect on proinflammatory mediators may have a role in these results. These data and the trend toward a decrease of endotoxin during the treatment warrant further investigation.
